课题基金 / 基金详情

Host Cellular responses accompanied by Epstein-Barr Virus genome replication.

Host Cellular responses accompanied by Epstein-Barr Virus genome replication.
宿主细胞反应伴随着 Epstein-Barr 病毒基因组复制。
批准号:
18390147
负责人:
TSURUMI Tatsuya
金额:
$10.69万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

TSURUMI Tatsuya的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Induction of the Epstein-Barr virus(EBV) lytic program elicits ATM-dependent DNA damage response, resulting in phosphorylation of p53 at Ser15, which, prevents interaction with MDM2. Nevertheless, p53-downstream signaling is blocked. We found here that during the lytic infection p53 was actively degraded in a proteasome-dependent manner even with a reduced level of MDM2. Turnover of p53 was stimulated in the lytic phase compared with that in the latent phase, indicating that EBV regulates p53 level also after induction of the lytic replication. Co-immunoprecipitation analysis revealed that the EBV BZLF1 immediate-early protein interacted with the DNA-binding domain near the N-terminus of p53. It was confirmed that BZLF1 protein elicited proteasome-dependent degradation of p53. and repressed the p53-mediated transactivation in SaOS-2 cells. The degradation of p53 was observed even in the presence of Nutlin-3, an inhibitor of p53-MDM2 interaction, and also in mouse embryo fibroblasts lacking mdm2 gene, indicating that the BZLF1 protein-induced degradation of p53 was independent of MDM2. Furthermore, Nutlin-3 increased the level of p53 in the latent phase of EBV infection but not in the lytic phase. Thus, although p53 level is regulated by MDM2 in the latent phase, it might be mediated by the BZLF1 protein-associated E3 ubiquitin ligase in the lytic phase, providing the insight that EBV regulates the cellular environment advantageous for lytic replication through degradation of p53, leading to inhibition of p53 downstream signaling pathway.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Postreplicative mismatch repair factors are recruited to Epstein-Barr virus replication compartment.
复制后错配修复因子被招募到 Epstein-Barr 病毒复制区室。
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Tsurumi T, Kudoh A, Daikoku T]
通讯作者: Daikoku T
DOI: 10.1038/sj.cgt.7701070
发表时间: 2007-11-01
期刊: CANCER GENE THERAPY
影响因子: 6.4
作者: [Kohno, S-i, Luo, C., Nishiyama, Y.]
通讯作者: Nishiyama, Y.
Paclitaxel-2'-Ethylcarbonate prodrug can circumvent P-glycoprotein-mediated cellular efflux to increase drug cytotoxicity.
Paclitaxel-2-Ethylcarbonate 前药可以规避 P-糖蛋白介导的细胞外流,从而增加药物的细胞毒性。
DOI: --
发表时间: 2007
期刊: Pharm Res 24(3)
影响因子: --
作者: [Tanino T, Nawa A, Kondo E, Kikkawa F, Daikoku T, Tsurumi T, Luo C, Nishiyama Y, Takayanagi Y, Nishimori K, Ichida S, Wada T, Miki Y, Iwaki M.]
通讯作者: Iwaki M.
DOI: 10.1074/jbc.m510314200
发表时间: 2006-04-21
期刊: JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子: 4.8
作者: [Daikoku, T, Kudoh, A, Tsurumi, T]
通讯作者: Tsurumi, T
13
    Architecture and Function of the Epstein-Barr virus Replication Compartment
    • 批准号:
      24659213
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      TSURUMI Tatsuya
    • 依托单位:
    Molecular basis for Epstein-Barr virus replication
    • 批准号:
      23390118
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.65万
    • 财政年份:
      2011
    • 负责人:
      TSURUMI Tatsuya
    • 依托单位:
    Epstein-Barr virus lytic replication and host factors supporting its replication
    • 批准号:
      20390137
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.65万
    • 财政年份:
      2008
    • 负责人:
      TSURUMI Tatsuya
    • 依托单位:
    Latent and lytic replication of Epstein-Barr virus.
    • 批准号:
      16017322
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $9.6万
    • 财政年份:
      2004
    • 负责人:
      TSURUMI Tatsuya
    • 依托单位:
    国内基金
    海外基金
    ATM-CHK2-P53通路在香港牡蛎高盐适应 中的作用及机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2025
    • 负责人:
      于非非
    • 依托单位:
    ATM/p53在异源三倍体鲫不育中的作用机制研究
    • 批准号:
      32373117
    • 项目类别:
      面上项目
    • 资助金额:
      50万元
    • 批准年份:
      2023
    • 负责人:
      王静
    • 依托单位:
    和厚朴酚脂质体通过ATM/Chk2/p53信号通路增强髓母细胞瘤化疗敏感性的机制研究
    • 批准号:
      82303822
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      李生兰
    • 依托单位:
    慢性炎症通过激活E2F8/ATM/p53信号轴诱导血管衰老的作用机制研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      55万元
    • 批准年份:
      2021
    • 负责人:
      康林
    • 依托单位: